These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9529559)

  • 1. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil.
    Traub A; Margulis SB; Stricker RB
    Dermatology; 1997; 195(4):369-73. PubMed ID: 9529559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease.
    Stricker RB; Goldberg B; Mills LB; Epstein WL
    Res Virol; 1997; 148(5):343-8. PubMed ID: 9403933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection.
    Stricker RB; Zhu YS; Elswood BF; Dumlao C; Van Elk J; Berger TG; Tappero J; Epstein WL; Kiprov DD
    Immunol Lett; 1993 Apr; 36(1):1-6. PubMed ID: 8102123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease.
    Stricker RB; Goldberg B; Epstein WL
    Immunol Lett; 1997 Dec; 59(3):145-50. PubMed ID: 9419021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Stricker RB; Goldberg B; Mills LB; Epstein WL
    J Am Acad Dermatol; 1995 Oct; 33(4):608-11. PubMed ID: 7673493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene.
    Stricker RB; Elswood BF; Goldberg B; Dumlao C; Van Elk J; Henry J; Winger EE; Epstein WL
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):462-6. PubMed ID: 8077474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy.
    Yoshizawa Y; Matsui H; Izaki S; Kitamura K; Maibach HI
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):258-62. PubMed ID: 10642682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of topical dinitrochlorobenzene.
    Stricker RB; Goldberg B
    Lancet; 1995 Nov; 346(8985):1293. PubMed ID: 7475731
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of lichen nitidus after topical dinitrochlorobenzene application.
    Kano Y; Otake Y; Shiohara T
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):305-8. PubMed ID: 9703140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulation of malignant melanoma by contact sensitizing agents.
    Trowbridge RM; Mitkov MV; Pittelkow MR; Agrawal DK
    Expert Rev Clin Immunol; 2014 Jan; 10(1):63-76. PubMed ID: 24308833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Smith KJ; Vidmar D; Skelton HG; Hackley BE
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):491-3. PubMed ID: 8784300
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic significance of delayed hypersensitivity to dinitrochlorobenzene and mechlorethamine hydrochloride in cutaneous T cell lymphoma.
    Vonderheid EC; Ekbote SK; Kerrigan K; Kalmanson JD; Van Scott EJ; Rook AH; Abrams JT
    J Invest Dermatol; 1998 Jun; 110(6):946-50. PubMed ID: 9620303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy with dinitrochlorobenzene (DNCB) for recurrent squamous cell tumor of conjunctiva.
    Ferry AP; Meltzer MA; Taub RN
    Trans Am Ophthalmol Soc; 1976; 74():154-71. PubMed ID: 325854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
    Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
    Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in plasma IL-10 levels and rapid loss of CD4+ T cells among HIV-infected individuals in south India.
    Srikanth P; Castillo RC; Sridharan G; John TJ; Zachariah A; Mathai D; Schwartz DH
    Int J STD AIDS; 2000 Jan; 11(1):49-51. PubMed ID: 10667901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up of HIV-1-infected Thai patients immunized with Remune monotherapy.
    Sukeepaisarncharoen W; Churdboonchart V; Kulpradist S; Isarangkura Na Ayudthya B; Rugpao S; Chandeying V; Sirawaraporn W; Carlo D; Moss RB
    HIV Clin Trials; 2001; 2(5):391-8. PubMed ID: 11673813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS.
    Stricker RB; Elswood BF
    Immunol Lett; 1991 Aug; 29(3):191-6. PubMed ID: 1769706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immunomodulatory effects of topical dinitrochlorobenzene (DNCB) in rats. Activity of peripheral blood polymorphonuclear cells.
    Belij S; Popov A; Zolotarevski L; Mirkov I; Djokic J; Kataranovski D; Kataranovski M
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):168-80. PubMed ID: 22222559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNCB for local control of malignant melanoma: don't forget a winning horse!
    Inbar M; Merimsky O; Adler A; Stein JA
    Melanoma Res; 1996 Dec; 6(6):457-9. PubMed ID: 9013484
    [No Abstract]   [Full Text] [Related]  

  • 20. The contact allergen dinitrochlorobenzene (DNCB) and respiratory allergy in the Th2-prone Brown Norway rat.
    Kuper CF; Stierum RH; Boorsma A; Schijf MA; Prinsen M; Bruijntjes JP; Bloksma N; Arts JH
    Toxicology; 2008 Apr; 246(2-3):213-21. PubMed ID: 18316151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.